Table 1 Comparison of intraoperative vital signs between the two groups.

From: Clinical outcomes of liposomal and conventional bupivacaine in postoperative pain management in female patients following thoracoscopic lung surgery

Vital signs

Group

 

LB, N = 25

BH, N = 25

P value

T1

 IBP, Median (IQR)

93 (87–102)

98 (90–104)

0.607

 HR, Median (IQR)

78 (69–85)

80 (70–84)

0.62

 SPO2, Median (IQR)

99(98 − 100)

99 (98–100)

0.266

 BIS, Median (IQR)

90 (88–91)

85 (80–90)

0.031

T2

 IBP, Median (IQR)

82 (79–95)

85 (76–98)

0.938

 HR, Median (IQR)

70 (60–78)

70 (60–78)

0.734

 SPO2, Median (IQR)

100 (98.250–100)

100 (100–100)

0.275

 BIS, Median (IQR)

52 (43–56)

48 (43–54)

0.308

T3

 IBP, Median (IQR)

88 (75–95)

80 (72–92)

0.478

 HR, Median (IQR)

70 (62–79)

69 (62–79)

0.946

 SPO2, Median (IQR)

100 (98–100)

100 (99–100)

0.297

 BIS, Median (IQR)

49 (40–56)

46 (44–55)

0.884

T4

 IBP, Median (IQR)

89 (82–95)

90 (83–92)

0.634

 HR, Median (IQR)

69 (61–76)

70 (62–78)

0.655

 SPO2, Median (IQR)

100 (100–100)

100 (100–100)

0.473

 BIS, Median (IQR)

55 (47–57)

51 (43–55)

0.778

Back to article page